Biocon reports 64% rise in Q4 consolidated net profit

26 Apr 2019 Evaluate

Biocon has reported results for the fourth quarter and year ended March 31, 2019. 

The company has reported a fall of 1.95% in its net profit at Rs 70.50 crore for the quarter ended March 31, 2019 as compared to Rs 71.90 crore for the same quarter in the previous year. Total income of the company increased by 14.50% at Rs 777.80 crore for quarter under review as compared to Rs 679.30 crore for the quarter ended March 31, 2018.

On consolidated basis, the company has reported rise of 63.88% in its net profit at Rs 213.70 crore for the quarter ended March 31, 2019 as compared to Rs 130.40 crore for the corresponding quarter in the FY18. Total consolidated income of the company rose 25.87% at Rs 1,557.00 crore for quarter under review as compared to Rs 1,237.00 crore for the same quarter ended previous year.

For the year ended March 31, 2019, the company has posted a 2-fold jump in its net profit at Rs 492.70 crore as compared to Rs 238.50 crore for the previous year. Total income of company increased 17.72% at Rs 3,002.20 crore for year under review as compared to Rs 2,550.20 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has posted 2-fold jump in its net profit at Rs 905.30 crore as compared to Rs 372.40 crore for the previous year. Total income of company increased by 30.51% at Rs 5,658.80 crore for year under review as compared to Rs 4,335.90 crore for year ended March 31, 2018.

Biocon Share Price

366.50 1.25 (0.34%)
28-Jan-2026 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.15
Dr. Reddys Lab 1223.65
Cipla 1315.60
Zydus Lifesciences 889.65
Lupin 2132.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×